Vascular Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Peripheral Stents, PTA Ballons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Peripheral Accessories, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters, By Application (Peripheral Arterial Disease (PAD), Aneurysms, Venous Diseases), By End-user (Hospitals, Ambulatory Surgical Centres), and Region Forecast 2020-2031

Vascular Devices Market size was valued at US$ 9,800 million in 2024 and is projected to reach US$ 13,900 million by 2031, expanding at a CAGR of 5.1% from 2025–2031. Moreover, the U.S. Vascular Devices Market is projected to grow significantly, reaching an estimated value of US$ 3,450 million by 2031, driven by rising cardiovascular disease prevalence, technological advancements, and growing demand for minimally invasive procedures.

The market plays a critical role in modern cardiovascular care, offering essential tools for the diagnosis, intervention, and management of vascular diseases. From routine angioplasties to complex peripheral interventions, these devices are the backbone of procedures that restore blood flow and prevent life-threatening events such as strokes or limb ischemia. A rising global burden of lifestyle-related conditions such as diabetes and hypertension has directly accelerated the demand for vascular access and treatment devices. Moreover, with hospitals focusing on minimally invasive procedures to reduce recovery time and complications, innovation in vascular technologies is advancing rapidly, bringing more precise, safer, and patient-friendly options to clinical practice.

Global health systems are now prioritizing early detection and minimally invasive management of cardiovascular diseases, giving vascular devices a central position in care protocols. The market’s growth trajectory is shaped by rapid aging populations, improved diagnostic infrastructure, and a strong preference for outpatient vascular procedures. Device miniaturization, drug-coated technologies, and hybrid stents are reshaping therapeutic strategies, especially in cases where conventional surgery poses high risk.

Facts & Figures

• Endovascular procedures now outpace open surgery in peripheral arterial disease treatment globally.
• The prevalence of vascular comorbidities is significantly higher among aging populations, particularly those over 65.
• Drug-coated devices are seeing rapid regulatory approvals in both Europe and the U.S.
• Ambulatory surgical centers are increasingly equipped to perform complex vascular interventions.

Key Developments

• In March 2024, Terumo launched a new portfolio of vascular closure devices in Southeast Asian markets, expanding its global footprint.
• In February 2025, Abbott announced a strategic acquisition of a vascular imaging startup to enhance precision-guided interventions.
• In January 2024, Medtronic received FDA approval for its next-generation drug-coated balloon targeting femoral artery lesions.

Vascular Devices Market Segmentation

Based on the type

• Peripheral Stents
• Iliac Artery Stents
• Femoral Artery Stents
• Carotid Artery Stents
• Renal Artery Stents
• Other Peripheral Stents
• PTA Balloons
• Catheters
• Angiography Catheters
• Guiding Catheters
• IVUS/OCT Catheters
• Endovascular Aneurysm Repair Stent Grafts
• Thoracic Endovascular Aneurysm Stent Grafts
• Abdominal Endovascular Aneurysm Stent Grafts
• Plaque Modification Devices
• Atherectomy Devices
• Thrombectomy Devices
• Peripheral Accessories
• Guidewires

• Workhorse Guidewires

• Specialty Guidewires

• Extra Support Guidewires

• Frontline Finesse Guidewires

• Peripheral Vascular Closure Devices
• Balloon Inflation Devices
• Introducer Sheaths
• Inferior Vena Cava Filters
• Permanent Filters
• Retrievable Filters
• Hemodynamic Flow Alteration Devices
• Chronic Total Occlusion Devices
• Embolic Protection Devices

Peripheral stents dominate the market as a first-line solution for restoring blood flow in occluded or narrowed peripheral arteries. These mesh-like tubes are implanted to support vessel walls, particularly in the iliac and femoral arteries, which are commonly affected in peripheral arterial disease. Their structural integrity, biocompatibility, and evolving drug-eluting capabilities make them a preferred choice among interventional specialists. Recent advancements in stent flexibility, radial strength, and deployment precision have further improved long-term patency rates and minimized complications like restenosis. As healthcare shifts toward outpatient endovascular procedures, demand for next-generation peripheral stents with enhanced durability and adaptability is growing rapidly, especially in high-volume centers treating complex arterial lesions.

Based on the application

• Peripheral Arterial Disease (PAD)
• Aneurysms
• Venous Diseases
• Others

Peripheral arterial disease (PAD) is the leading application segment in the market, driven by its high prevalence and associated morbidity. PAD restricts blood flow to limbs due to plaque buildup, requiring intervention to prevent tissue damage or amputation. Vascular devices such as stents, angioplasty balloons, atherectomy systems, and thrombectomy tools are essential in managing moderate to severe PAD cases. The shift toward minimally invasive techniques has made endovascular therapies the preferred approach for PAD, replacing traditional surgical bypass in many cases. Aging populations, smoking habits, and diabetes prevalence continue to expand the PAD patient pool, reinforcing the clinical importance and commercial demand for targeted vascular technologies.

Based on the end user

• Hospitals
• Ambulatory Surgical Centers
• Others

Hospitals remain the primary end-users of vascular devices, accounting for a significant portion of procedural volume across both elective and emergency interventions. Equipped with skilled personnel, advanced imaging, and surgical backup, hospitals are uniquely positioned to handle complex vascular cases, including aneurysm repairs, carotid interventions, and PAD management. Their role is further cemented by their ability to conduct multidisciplinary procedures involving cardiologists, vascular surgeons, and radiologists. Additionally, hospitals act as early adopters of innovative technologies, often participating in clinical trials and post-market surveillance. With growing investments in hybrid operating rooms and digital health infrastructure, hospitals continue to lead in the adoption and advancement of next-generation vascular device solutions.